FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...